367 related articles for article (PubMed ID: 17349887)
1. Evidence for functional heterogeneity of circulating B-type natriuretic peptide.
Liang F; O'Rear J; Schellenberger U; Tai L; Lasecki M; Schreiner GF; Apple FS; Maisel AS; Pollitt NS; Protter AA
J Am Coll Cardiol; 2007 Mar; 49(10):1071-8. PubMed ID: 17349887
[TBL] [Abstract][Full Text] [Related]
2. Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Lam CS; Burnett JC; Costello-Boerrigter L; Rodeheffer RJ; Redfield MM
J Am Coll Cardiol; 2007 Mar; 49(11):1193-202. PubMed ID: 17367664
[TBL] [Abstract][Full Text] [Related]
3. Analytical relationships among Biosite, Bayer, and Roche methods for BNP and NT-proBNP.
Sykes E; Karcher RE; Eisenstadt J; Tushman DA; Balasubramaniam M; Gusway J; Perason VJ
Am J Clin Pathol; 2005 Apr; 123(4):584-90. PubMed ID: 15743748
[TBL] [Abstract][Full Text] [Related]
4. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
5. Performance characteristics of four automated natriuretic peptide assays.
Rawlins ML; Owen WE; Roberts WL
Am J Clin Pathol; 2005 Mar; 123(3):439-45. PubMed ID: 15716241
[TBL] [Abstract][Full Text] [Related]
6. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
7. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
Omland T
Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
[TBL] [Abstract][Full Text] [Related]
8. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
Koch AM; Rauh M; Zink S; Singer H
Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
[TBL] [Abstract][Full Text] [Related]
9. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.
Bionda C; Bergerot C; Ardail D; Rodriguez-Lafrasse C; Rousson R
Ann Clin Lab Sci; 2006; 36(3):299-306. PubMed ID: 16951271
[TBL] [Abstract][Full Text] [Related]
10. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
Niederkofler EE; Kiernan UA; O'Rear J; Menon S; Saghir S; Protter AA; Nelson RW; Schellenberger U
Circ Heart Fail; 2008 Nov; 1(4):258-64. PubMed ID: 19808300
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP.
Mair J; Falkensammer G; Poelzl G; Hammerer-Lercher A; Griesmacher A; Pachinger O
Clin Chim Acta; 2007 Apr; 379(1-2):163-6. PubMed ID: 17258185
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure.
Miller WL; Phelps MA; Wood CM; Schellenberger U; Van Le A; Perichon R; Jaffe AS
Circ Heart Fail; 2011 May; 4(3):355-60. PubMed ID: 21292992
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparison of B-type natriuretic peptide (BNP) and NT-proBNP in daily clinical practice.
Mair J; Gerda F; Renate H; Ulmer H; Andrea G; Pachinger O
Int J Cardiol; 2008 Feb; 124(2):244-6. PubMed ID: 17360054
[TBL] [Abstract][Full Text] [Related]
14. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D
Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide enhances vasculogenesis by promoting number and functional properties of early endothelial progenitor cells.
Shmilovich H; Ben-Shoshan J; Tal R; Afek A; Barshack I; Maysel-Auslander S; Harats D; Keren G; George J
Tissue Eng Part A; 2009 Sep; 15(9):2741-9. PubMed ID: 19275472
[TBL] [Abstract][Full Text] [Related]
16. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide in heart failure.
Moe GW
Curr Opin Cardiol; 2006 May; 21(3):208-14. PubMed ID: 16601459
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure].
Rutten JH; Boomsma F; Van den Meiracker AH
Ned Tijdschr Geneeskd; 2007 Nov; 151(46):2553-7. PubMed ID: 18074722
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the analytical performance characteristics of NT-proBNP immunoassay on dimension RxL-HM (Dade Behring)].
Benoit MO; Dautezac F; Taccoen M; Paul JL
Ann Biol Clin (Paris); 2005; 63(4):411-6. PubMed ID: 16061439
[TBL] [Abstract][Full Text] [Related]
20. Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.
Birner CM; Ulucan C; Fredersdorf S; Rihm M; Löwel H; Stritzke J; Schunkert H; Hengstenberg C; Holmer S; Riegger G; Luchner A
Cytokine; 2007 Nov; 40(2):89-97. PubMed ID: 17920926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
